<DOC>
	<DOCNO>NCT00151476</DOCNO>
	<brief_summary>This registry-based observational study assess clinical outcome FAP patient receive celecoxib compare historical/concurrent registry patient receive celecoxib . Both retrospective prospective data utilize . No sample method apply .</brief_summary>
	<brief_title>Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared Control Patients</brief_title>
	<detailed_description>The study prematurely discontinue April 11 , 2008 due slow enrollment . It note safety concern see study factor decision .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Adenomatous Polyposis Coli</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Celecoxib Treated Patients : Diagnosis FAP base expression FAP phenotype . Celecoxib treatment prescribe outside clinical trial set expect duration celecoxib treatment least six month . Historical/Concurrent Control Patients : Diagnosis FAP base expression FAP phenotype . Be great equal 12 year old time study enrollment . Have endoscopically assessable colonic , rectal , ileal pouch and/or gastroduodenal segment . For group postsurgical patient , IRA IPAA perform 1985 onward ( order assure standardize surgical technique postsurgical management ) . Patients whose primary colorectal surgery perform prior 1985 eligible serve historical control . Celecoxib Treated Patients : Have receive pharmacological treatment ( celecoxib ) within last 3 month FAP disease include treatment extracolonic manifestation FAP . Have receive nonsteroidal antiinflammatory drug ( NSAID ) within last 3 month , celecoxib , reason . Historical/Concurrent Control Patients : Have pharmacological treatment record FAP disease define index date . Have receive nonsteroidal antiinflammatory drug ( NSAID ) within last 3 month reason .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Familial adenomatous polyposis</keyword>
	<keyword>celecoxib</keyword>
	<keyword>IRA</keyword>
	<keyword>IPAA</keyword>
</DOC>